Mémoire de bachelor : Haute école de santé Genève, 2021.
Le but de notre travail est d'apporter un complément aux revues systématiques déjà existantes sur l'administration de vitamine B12 ou D chez les patients atteints de neuropathies diabétiques. Nous voulons déterminer si d'autres micronutriments permettent d'améliorer la fonction nerveuse ou les signes et symptômes des patients.
|
In: Current Diabetes Reports, 2015, vol. 15, no. 4, p. 1-13
|
In: Clinical Rheumatology, 2015, vol. 34, no. 3, p. 591-596
|
In: Journal of Clinical Monitoring and Computing, 2015, vol. 29, no. 4, p. 499-507
|
In: Journal of Neurology, 2015, vol. 262, no. 4, p. 870-880
|
In: Journal of General Internal Medicine, 2015, vol. 30, no. 8, p. 1193-1203
|
In: European Radiology, 2015, vol. 25, no. 11, p. 3405-3413
|
In: Journal of Clinical Monitoring and Computing, 2015, vol. 29, no. 2, p. 203-207
|
In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 26, no. 6, p. 977-984
|
In: PLOS genetics, 2019, vol. 15, no. 4, p. e1008069
In the peripheral nervous system (PNS) myelinating Schwann cells synthesize large amounts of myelin protein zero (P0) glycoprotein, an abundant component of peripheral nerve myelin. In humans, mutations in P0 cause the demyelinating Charcot-Marie-Tooth 1B (CMT1B) neuropathy, one of the most diffused genetic disorders of the PNS. We previously showed that several mutations, such as the...
|